According to multiple media reports on Thursday, Pfizer Inc. (NYSE:PFE) has terminated the global development and ...

which has an easy auto-injector mechanism. “These marketing authorisations constitute significant milestones for Novo Nordisk and the treatment of diabetes. We look forward to making Tresiba and ...

NH Business Review will honor more than 50 businesses throughout the Granite State during its 18 th annual Best of Business ...

But this week, the stock jumped again after Amgen issued a strong financial update Tuesday. Its rise helped push up the S&P 500 healthcare sector up just over 7% since hitting a b ...

Even injection discomfort is reduced by needle-free and auto-injector technologies ... Sogroya (Somapacitan): Novo Nordisk Sogroya (Somapacitan) is a human growth hormone analog that is administered ...

Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Well, at least for Novo Nordisk's Ozempic and Wegovy ... order" confirming the "resolution of shortages of semaglutide injection products ... Ozempic and Wegovy." Two of Novo's biggest money ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...

Novo Nordisk, manufacturer of the weight loss jab Wegovy, has been reprimanded for allegedly failing to disclose or accurately report payments to healthcare and patient organisations (Alamy/PA ...